Great Novel Therapeutics Biotech & Medicals (TPEX:7427)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
33.20
+2.35 (7.62%)
Apr 20, 2026, 1:24 PM CST

TPEX:7427 Statistics

Total Valuation

TPEX:7427 has a market cap or net worth of TWD 1.46 billion. The enterprise value is 1.02 billion.

Market Cap1.46B
Enterprise Value 1.02B

Important Dates

The next estimated earnings date is Wednesday, August 12, 2026.

Earnings Date Aug 12, 2026
Ex-Dividend Date n/a

Share Statistics

TPEX:7427 has 42.95 million shares outstanding. The number of shares has increased by 12.53% in one year.

Current Share Class 42.95M
Shares Outstanding 42.95M
Shares Change (YoY) +12.53%
Shares Change (QoQ) -0.87%
Owned by Insiders (%) 13.09%
Owned by Institutions (%) n/a
Float 35.84M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 1,211.92
PB Ratio 2.90
P/TBV Ratio 3.07
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -10.47
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF -11.62

Financial Position

The company has a current ratio of 24.12, with a Debt / Equity ratio of 0.01.

Current Ratio 24.12
Quick Ratio 23.19
Debt / Equity 0.01
Debt / EBITDA n/a
Debt / FCF -0.08
Interest Coverage -1,026.23

Financial Efficiency

Return on equity (ROE) is -17.16% and return on invested capital (ROIC) is -10.78%.

Return on Equity (ROE) -17.16%
Return on Assets (ROA) -10.46%
Return on Invested Capital (ROIC) -10.78%
Return on Capital Employed (ROCE) -19.62%
Weighted Average Cost of Capital (WACC) 4.69%
Revenue Per Employee 80,333
Profits Per Employee -6.50M
Employee Count15
Asset Turnover 0.00
Inventory Turnover 0.46

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -15.96% in the last 52 weeks. The beta is 0.08, so TPEX:7427's price volatility has been lower than the market average.

Beta (5Y) 0.08
52-Week Price Change -15.96%
50-Day Moving Average 32.84
200-Day Moving Average 34.00
Relative Strength Index (RSI) 45.68
Average Volume (20 Days) 146,033

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, TPEX:7427 had revenue of TWD 1.21 million and -97.47 million in losses. Loss per share was -2.26.

Revenue1.21M
Gross Profit -1.18M
Operating Income -99.54M
Pretax Income -97.47M
Net Income -97.47M
EBITDA -91.86M
EBIT -99.54M
Loss Per Share -2.26
Full Income Statement

Balance Sheet

The company has 447.54 million in cash and 7.45 million in debt, with a net cash position of 440.09 million or 10.25 per share.

Cash & Cash Equivalents 447.54M
Total Debt 7.45M
Net Cash 440.09M
Net Cash Per Share 10.25
Equity (Book Value) 502.98M
Book Value Per Share 11.69
Working Capital 447.11M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -87.56 million and capital expenditures -280,000, giving a free cash flow of -87.84 million.

Operating Cash Flow -87.56M
Capital Expenditures -280,000
Depreciation & Amortization 4.80M
Net Borrowing -3.00M
Free Cash Flow -87.84M
FCF Per Share -2.05
Full Cash Flow Statement

Margins

Gross Margin -98.26%
Operating Margin -8,260.91%
Pretax Margin -8,089.05%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

TPEX:7427 does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -12.53%
Shareholder Yield -12.53%
Earnings Yield -6.67%
FCF Yield -6.01%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1